Mr. Paul Firuta joined uniQure as Chief Commercial Officer in May 2016 with 25 years of industry experience successfully commercializing products targeting rare diseases.
Mr. Firuta joined from BioBlast Pharma (NASDAQ: ORPN) where he held the position of Chief Commercial Officer. Prior to this, he was President of U.S. Commercial Operations at NPS Pharmaceuticals where he led the development and execution of the GATTEX sales and marketing plan as well as the commercial launch of NAPTARA. Over the course of his career, Mr. Firuta has held various leadership roles at biopharmaceutical companies including Vice President and General Manager, Americas at ViroPharma, Inc. where he was responsible for U.S. commercial operations for CINRYZE and VANCOCIN, representing over $400 million in U.S. revenue. Additionally, he was Vice President – Managed Markets at LEV Pharmaceuticals and Executive Director National Accounts at OraPharma.
Mr. Firuta holds a Master of Business Administration from St. Joseph’s University in Philadelphia, Pennsylvania and a Bachelor of Science degree from King’s College, Wilkes-Barre, Pennsylvania.